The Live Ahmedabad
  • Home
  • Ahd City
  • Surat
  • Vadodara
  • Rajkot
  • Business
  • Entertainment
  • Education
  • Crime
  • Health
  • Politics
  • Sports
  • Featured

The Live Ahmedabad

  • Home
  • Ahd City
  • Surat
  • Vadodara
  • Rajkot
  • Business
  • Entertainment
  • Education
  • Crime
  • Health
  • Politics
  • Sports
  • Featured
Nation

COVID Vaccine for 15-18 Years: Children can register on CoWIN app from Jan 1

by TLAteam December 27, 2021December 27, 2021
written by TLAteam December 27, 2021December 27, 2021
COVID Vaccine for 15-18 Years: Children can register on CoWIN app from Jan 1

As India is all set to roll out vaccines for the age group of 15-18 years the central government on Monday informed the children will be able to register on the CoWIN app from January 1.

Dr. RS Sharma, CoWIN platform Chief informed that children in the age group of 15-18 years will be able to register on the CoWIN app from January 1. The children will be required to submit ‘student id cards’ for the registration process for Covid vaccination, Sharma added. “We’ve added an additional (10th) ID card for registration – the student ID card because some might not have Aadhaar or other identity cards” Dr Sharma added.

Meanwhile, the registration process for senior citizens above 60 years will be exactly the same. If you are above 60 years of age and have taken both doses and the gap between the second dose and the day you are registering is more than 9 months (39 weeks) then you are eligible Dr Sharma said.

When you will register, it will ask whether you have any comorbidities or not. If you say yes, you will be able to book and have to show the comorbidities certificate from registered doctor at the vaccination centre and then you can get jabs: Dr Sharma added.

Prime Minister Narendra Modi on December 25 announced that vaccination against COVID-19 for children between 15-18 years will start from January 3, while “precaution dose” for healthcare and frontline workers would be administered from January 10. The decisions came amid rising Covid cases linked to the Omicron variant of the virus.

Covaxin has shown that it has a very good immune response in children in trials, Dr NK Arora, Chairman of Covid Task Force working group, NTAGI, said

0 comment
previous post
Unseasonal rain expected in North Gujarat on Dec 28
next post
Woman loses Rs 1.9 lakh in a gift offer scam

You may also like

New rules for delayed birth and death registration...

September 17, 2026

Repo Rate Alert: RBI may increase rates, borrowers...

September 16, 2026

Rohit, Virat back in India squads for WI...

September 16, 2026

Kayadu Lohar Turns Up the Heat in Stunning...

September 16, 2026

Flipkart Big Billion Days 2026 sale starts October...

September 16, 2026

UPI Payments Above Rs 2,000 to Attract 0.4%...

September 16, 2026

Taapsee Pannu Shares Stunning Bikini Pictures From Her...

September 15, 2026

Government Prohibits Charges on RuPay Debit Card, UPI...

September 15, 2026

Radhika Madan Sets the Beach Ablaze in Stunning...

September 14, 2026

CBI Registers FIR in Death Case of Sushant...

September 14, 2026
[bsa_pro_ad_space id=7]

Recent Posts

  • 35 RTE admissions in Ahmedabad under scrutiny over parents’ income

    September 17, 2026
  • Science City marks World Ozone Day with students

    September 17, 2026
  • Ahmedabad Navratri domes must have 2 emergency exits, 1 sq m space per person

    September 17, 2026
  • Gujarat to see another spell of rain, strong winds likely for next 3 days

    September 17, 2026
  • Technical glitch delays driving tests at Darjipura RTO

    September 17, 2026
December 2021
MTWTFSS
 12345
6789101112
13141516171819
20212223242526
2728293031 
« Nov Jan »
The Live Ahmedabad
Footer Logo
  • Home
  • Ahd City
  • Surat
  • Vadodara
  • Rajkot
  • Business
  • Entertainment
  • Education
  • Crime
  • Health
  • Politics
  • Sports
  • Featured
  • Privacy Policy
  • Disclaimer
  • Cookie Policy
  • Terms of use
  • Advertise with Us
  • Work With Us
  • Contact Us

© 2021 - The Live Ahmedabad. All Rights Reserved.